COPD Therapeutics Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global COPD Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Bronchodilators
        1.2.3 Inhaled Corticosteroids
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global COPD Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Adult
        1.3.3 Child
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global COPD Therapeutics Market Perspective (2017-2028)
    2.2 COPD Therapeutics Growth Trends by Region
        2.2.1 COPD Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 COPD Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 COPD Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 COPD Therapeutics Market Dynamics
        2.3.1 COPD Therapeutics Industry Trends
        2.3.2 COPD Therapeutics Market Drivers
        2.3.3 COPD Therapeutics Market Challenges
        2.3.4 COPD Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top COPD Therapeutics Players by Revenue
        3.1.1 Global Top COPD Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global COPD Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global COPD Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by COPD Therapeutics Revenue
    3.4 Global COPD Therapeutics Market Concentration Ratio
        3.4.1 Global COPD Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by COPD Therapeutics Revenue in 2021
    3.5 COPD Therapeutics Key Players Head office and Area Served
    3.6 Key Players COPD Therapeutics Product Solution and Service
    3.7 Date of Enter into COPD Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 COPD Therapeutics Breakdown Data by Type
    4.1 Global COPD Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global COPD Therapeutics Forecasted Market Size by Type (2023-2028)
5 COPD Therapeutics Breakdown Data by Application
    5.1 Global COPD Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global COPD Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America COPD Therapeutics Market Size (2017-2028)
    6.2 North America COPD Therapeutics Market Size by Type
        6.2.1 North America COPD Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America COPD Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America COPD Therapeutics Market Share by Type (2017-2028)
    6.3 North America COPD Therapeutics Market Size by Application
        6.3.1 North America COPD Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America COPD Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America COPD Therapeutics Market Share by Application (2017-2028)
    6.4 North America COPD Therapeutics Market Size by Country
        6.4.1 North America COPD Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America COPD Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe COPD Therapeutics Market Size (2017-2028)
    7.2 Europe COPD Therapeutics Market Size by Type
        7.2.1 Europe COPD Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe COPD Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe COPD Therapeutics Market Share by Type (2017-2028)
    7.3 Europe COPD Therapeutics Market Size by Application
        7.3.1 Europe COPD Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe COPD Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe COPD Therapeutics Market Share by Application (2017-2028)
    7.4 Europe COPD Therapeutics Market Size by Country
        7.4.1 Europe COPD Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe COPD Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific COPD Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific COPD Therapeutics Market Size by Type
        8.2.1 Asia-Pacific COPD Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific COPD Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific COPD Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific COPD Therapeutics Market Size by Application
        8.3.1 Asia-Pacific COPD Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific COPD Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific COPD Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific COPD Therapeutics Market Size by Region
        8.4.1 Asia-Pacific COPD Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific COPD Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America COPD Therapeutics Market Size (2017-2028)
    9.2 Latin America COPD Therapeutics Market Size by Type
        9.2.1 Latin America COPD Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America COPD Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America COPD Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America COPD Therapeutics Market Size by Application
        9.3.1 Latin America COPD Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America COPD Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America COPD Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America COPD Therapeutics Market Size by Country
        9.4.1 Latin America COPD Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America COPD Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa COPD Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa COPD Therapeutics Market Size by Type
        10.2.1 Middle East & Africa COPD Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa COPD Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa COPD Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa COPD Therapeutics Market Size by Application
        10.3.1 Middle East & Africa COPD Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa COPD Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa COPD Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa COPD Therapeutics Market Size by Country
        10.4.1 Middle East & Africa COPD Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa COPD Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Details
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline COPD Therapeutics Introduction
        11.1.4 GlaxoSmithKline Revenue in COPD Therapeutics Business (2017-2022)
        11.1.5 GlaxoSmithKline Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca COPD Therapeutics Introduction
        11.2.4 AstraZeneca Revenue in COPD Therapeutics Business (2017-2022)
        11.2.5 AstraZeneca Recent Developments
    11.3 Theravance Biopharma
        11.3.1 Theravance Biopharma Company Details
        11.3.2 Theravance Biopharma Business Overview
        11.3.3 Theravance Biopharma COPD Therapeutics Introduction
        11.3.4 Theravance Biopharma Revenue in COPD Therapeutics Business (2017-2022)
        11.3.5 Theravance Biopharma Recent Developments
    11.4 Mylan
        11.4.1 Mylan Company Details
        11.4.2 Mylan Business Overview
        11.4.3 Mylan COPD Therapeutics Introduction
        11.4.4 Mylan Revenue in COPD Therapeutics Business (2017-2022)
        11.4.5 Mylan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global COPD Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Bronchodilators
    Table 3. Key Players of Inhaled Corticosteroids
    Table 4. Key Players of Other
    Table 5. Global COPD Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global COPD Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global COPD Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global COPD Therapeutics Market Share by Region (2017-2022)
    Table 9. Global COPD Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global COPD Therapeutics Market Share by Region (2023-2028)
    Table 11. COPD Therapeutics Market Trends
    Table 12. COPD Therapeutics Market Drivers
    Table 13. COPD Therapeutics Market Challenges
    Table 14. COPD Therapeutics Market Restraints
    Table 15. Global COPD Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global COPD Therapeutics Revenue Share by Players (2017-2022)
    Table 17. Global Top COPD Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2021)
    Table 18. Ranking of Global Top COPD Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by COPD Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players COPD Therapeutics Product Solution and Service
    Table 22. Date of Enter into COPD Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global COPD Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global COPD Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global COPD Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global COPD Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global COPD Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global COPD Therapeutics Revenue Share by Application (2017-2022)
    Table 30. Global COPD Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global COPD Therapeutics Revenue Share by Application (2023-2028)
    Table 32. North America COPD Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America COPD Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America COPD Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America COPD Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America COPD Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America COPD Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe COPD Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe COPD Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe COPD Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe COPD Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe COPD Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe COPD Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific COPD Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific COPD Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific COPD Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific COPD Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific COPD Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific COPD Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America COPD Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America COPD Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America COPD Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America COPD Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America COPD Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America COPD Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa COPD Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa COPD Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa COPD Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa COPD Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa COPD Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa COPD Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. GlaxoSmithKline Company Details
    Table 63. GlaxoSmithKline Business Overview
    Table 64. GlaxoSmithKline COPD Therapeutics Product
    Table 65. GlaxoSmithKline Revenue in COPD Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. GlaxoSmithKline Recent Developments
    Table 67. AstraZeneca Company Details
    Table 68. AstraZeneca Business Overview
    Table 69. AstraZeneca COPD Therapeutics Product
    Table 70. AstraZeneca Revenue in COPD Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. AstraZeneca Recent Developments
    Table 72. Theravance Biopharma Company Details
    Table 73. Theravance Biopharma Business Overview
    Table 74. Theravance Biopharma COPD Therapeutics Product
    Table 75. Theravance Biopharma Revenue in COPD Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Theravance Biopharma Recent Developments
    Table 77. Mylan Company Details
    Table 78. Mylan Business Overview
    Table 79. Mylan COPD Therapeutics Product
    Table 80. Mylan Revenue in COPD Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Mylan Recent Developments
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global COPD Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Bronchodilators Features
    Figure 3. Inhaled Corticosteroids Features
    Figure 4. Other Features
    Figure 5. Global COPD Therapeutics Market Share by Application: 2021 VS 2028
    Figure 6. Adult Case Studies
    Figure 7. Child Case Studies
    Figure 8. COPD Therapeutics Report Years Considered
    Figure 9. Global COPD Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global COPD Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global COPD Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global COPD Therapeutics Market Share by Players in 2021
    Figure 13. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by COPD Therapeutics Revenue in 2021
    Figure 15. North America COPD Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America COPD Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 17. North America COPD Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 18. North America COPD Therapeutics Market Size Share by Country (2017-2028)
    Figure 19. United States COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe COPD Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe COPD Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 23. Europe COPD Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 24. Europe COPD Therapeutics Market Size Share by Country (2017-2028)
    Figure 25. Germany COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific COPD Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific COPD Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific COPD Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific COPD Therapeutics Market Size Share by Region (2017-2028)
    Figure 35. China COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America COPD Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America COPD Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America COPD Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America COPD Therapeutics Market Size Share by Country (2017-2028)
    Figure 45. Mexico COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa COPD Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa COPD Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa COPD Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa COPD Therapeutics Market Size Share by Country (2017-2028)
    Figure 51. Turkey COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE COPD Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. GlaxoSmithKline Revenue Growth Rate in COPD Therapeutics Business (2017-2022)
    Figure 55. AstraZeneca Revenue Growth Rate in COPD Therapeutics Business (2017-2022)
    Figure 56. Theravance Biopharma Revenue Growth Rate in COPD Therapeutics Business (2017-2022)
    Figure 57. Mylan Revenue Growth Rate in COPD Therapeutics Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed